Skip to content

This website is intended for UK healthcare professionals only

This is a promotional website developed by AstraZeneca

The prescribing information can be found at the bottom of the page

bars

Tagrisso Case Study: First line EGFRm+ NSCLC – 71F

Dr Tom Newsom-Davis, Consultant Medical Oncologist, Chelsea and Westminster NHS Foundation Trust


BACK